4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-18-000896
Director sold 7,118 shares at $63.00 ($448,434)
- Director acquired 7,118 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KROLL MARK W · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-01-02 | Exercise or conversion : show line 1 in the form | +7,118 | $34.41 | $244,895 | 33,881 | D |
| 2018-01-02 | Sale : show line 2 in the form | −7,118 | $63.00 | $448,434 | 26,763 | D |
| Open-market sales · 7,118 sh · avg $63.00 · $448,434 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-01-02 | Exercise or conversion : show line 3 in the form Non-qualified Stock Option (Right to Buy) | −7,118 | 0 | D |
Loading xslF345X03/form4.xml…